Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZAI LAB

29.650
+1.1003.85%
Volume:12.08M
Turnover:350.12M
Market Cap:32.70B
PE:-14.54
High:29.700
Open:28.550
Low:27.700
Close:28.550
Loading ...

Zai Lab Ltd. Chairperson & CEO Du Ying Reports Disposal of Common Shares

Reuters
·
14 May

HK Movers | HK's Biotech Shares Pull Back. Alphamab, Cstone Pharma, Ascletis down about 10%; Immuneonco, Laekna down over 9%

Tiger Newspress
·
12 May

Zai Lab Shrinks Loss in Q1 as Revenue Jumps 22%

MT Newswires Live
·
09 May

Stock Track | ZAI LAB Soars 5.15% as Company Complies with HFCAA, Avoiding Delisting Risk

Stock Track
·
09 May

BRIEF-Zai Lab Complies With HFCAA

Reuters
·
08 May

Zai Lab Ltd: Complies With the Hfcaa; Not Subject to Delisting

THOMSON REUTERS
·
08 May

Zai Lab Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Zai Lab Ltd: on Track to Achieve Profitability in Q4 2025

THOMSON REUTERS
·
08 May

Zai Lab Ltd: Reaffirming Full-Year 2025 Revenue Guidance

THOMSON REUTERS
·
08 May

Zai Lab Ltd expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
06 May

HK Movers | Biotech Stocks Rally With Zai Lab up 8%

Tiger Newspress
·
23 Apr

BRIEF-Zai Lab Announces Acceptance Of Supplemental New Drug Application For Repotrectinib For Patients With NTRK-Positive Solid Tumors

Reuters
·
21 Apr

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients With Ntrk-Positive Solid Tumors

THOMSON REUTERS
·
21 Apr

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
14 Apr

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
09 Apr

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
09 Apr

BUZZ-HK-listed Zai Lab hits 2-year peak on higher product revenue

Reuters
·
28 Mar

Stock Track | Zai Lab Soars 5.23% as Annual Revenue Jumps Despite Net Loss

Stock Track
·
28 Mar

BRIEF-Zai Lab Posts FY Net Loss $257.1 Million

Reuters
·
28 Mar

Zai Lab - FY Net Product Revenue Increased to $397.6 Mln

THOMSON REUTERS
·
28 Mar